These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy. Cinque P; Casari S; Bertelli D N Engl J Med; 1998 Sep; 339(12):848-9. PubMed ID: 9750081 [No Abstract] [Full Text] [Related]
36. Progressive multifocal leukoencephalopathy. A cause of visual loss. Appen RE; Roth H; ZuRhein GM; Varakis JN Arch Ophthalmol; 1977 Apr; 95(4):656-9. PubMed ID: 849189 [TBL] [Abstract][Full Text] [Related]
37. Convection-enhanced intraparenchymal delivery (CEID) of cytosine arabinoside (AraC) for the treatment of HIV-related progressive multifocal leukoencephalopathy (PML). Levy RM; Major E; Ali MJ; Cohen B; Groothius D J Neurovirol; 2001 Aug; 7(4):382-5. PubMed ID: 11517421 [TBL] [Abstract][Full Text] [Related]
39. [Progressive multifocal leukoencephalopathy as the initial manifestation of acquired immunologic deficiency syndrome]. Sánchez Herrero J; López Facal S; Arnal Monreal F; Marín Sánchez M; de la Fuente Fernández R; Rey del Corral P Med Clin (Barc); 1988 Mar; 90(10):416-8. PubMed ID: 3398612 [No Abstract] [Full Text] [Related]
40. Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient. Major EO; Ault GS Curr Opin Neurol; 1995 Jun; 8(3):184-90. PubMed ID: 7551117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]